ABO blood group screening results among blood donors in Guangzhou from 2021 to 2022

Journal Title: Chinese Journal of Blood Transfusion - Year 2024, Vol 37, Issue 4

Abstract

Objective To investigate the distribution of ABO and RhD blood groups among voluntary blood donors in Guangzhou, in order to ensure clinical blood safety and better serve blood donors. Methods Routine ABO and RhD blood group screening tests were carried out among voluntary blood donors from January 2021 to December 2022. The composition ratio of ABO blood group was statistically analyzed. The samples with discrepancy between forward and reverse blood grouping and negative RhD blood group samples were further verified by serological test to analyze the ABO subtypes and the reasons for missed detection. Results A total of 749 123 blood samples were screened from January 2021 to December 2022, and 513 291 samples were collected after excluding repeat blood donors, with the ABO blood groups as 208 126(40.55%) of O type, 138 859(27.05%) of A type, 130 987(25.52%) of B type and 35 319(6.88%) of AB type. The screening results showed discrepancy between forward and reverse blood grouping in 506 samples, of which 58 were with weak/non-erythrocyte reaction, 16 with erythrocyte reaction, 215 with weak/non-serum reaction, and 217 with serum reaction. Further serological test indicated that 44 samples were ABO subtypes, among which 13 were subtype A, 26 subtype B, 5 subtype AB and 3 B (A) and 14 Bombay-like blood group. The blood group with the highest missed detection rate in repeat blood donors were A3/B3 subtype (68.42%). A total of 128 unexpected antibody positive samples were detected among 513 291 samples A total of 2 277 samples were screened negative for RhD blood type, of which 2 188 were confirmed to be Rh negative (2 188/513 291, 0.43%), 89 were D variants (89/513 291, 0.02%, ) and 30 were detected with unexpected antibodies (30/2 188, 1.37%). Conclusion The ABO blood group distribution of blood donors in Guangzhou is O>A>B>AB, and the proportion of RhD negative population is 0.43%, slightly highter than 0.3%-0.4% of Han population nationwide. The ABO blood group subtype is dominated by B subtype. The detection rate and missed detection rate of A3/B3 subtypes in routine blood group tests are the highest.

Authors and Affiliations

Xuying LIU, Boquan HUANG, Fenfang LIAO, Zhongping LI, Haojian LIANG, Rongsong DU, Junmou XIE, Aiqiong HUANG, Hao WANG

Keywords

Related Articles

Amplification efficiency and cost analysis of MP-NAT and ID-NAT in blood samples

Objective To compare the performance and cost-effectiveness between ID-NAT (individual detection of NAT) mode and MP-NAT (mini-pool nucleic acid test) mode in blood screening, and to provide reference for blood sample de...

Skin injury around enterostomy cured by allogeneic platelet-rich plasma: a report of two cases

Objective To investigate the feasibility of allogeneic platelet-rich plasma (PRP) for the treatment of skin injury around enterostomy. Methods The treatment process by PRP of 2 patients with skin injury around enterostom...

Distribution and transfusion efficacy of unexpected antibody

Objective To investigate the clinical characteristics and antibody distribution as well as evaluate the transfusion efficacy in unexpected antibody positive patients. Methods A total of 12 235 patients from January 1, 20...

Factors affecting the efficacy of platelet transfusion and specificity of HLA-Ⅰ antibodies in tumor patients

Objective To analyze the factors affecting the efficacy of platelet transfusion and the specificity of HLA-Ⅰ antibodies in tumor patients. Methods Tumer patients applied for platelet transfusion from November 2019 to Jul...

Identification of antibody against highly prevalent antigen through serological test and molecular biology technology

Objective To identify a case of antibody against highly prevalent antigen through molecular biology technology. Methods Blood group typing, unexpected antibody identification and cross matching were performed by serologi...

Download PDF file
  • EP ID EP738801
  • DOI 10.13303/j.cjbt.issn.1004-549x.2024.04.011
  • Views 35
  • Downloads 0

How To Cite

Xuying LIU, Boquan HUANG, Fenfang LIAO, Zhongping LI, Haojian LIANG, Rongsong DU, Junmou XIE, Aiqiong HUANG, Hao WANG (2024). ABO blood group screening results among blood donors in Guangzhou from 2021 to 2022. Chinese Journal of Blood Transfusion, 37(4), -. https://europub.co.uk/articles/-A-738801